BRILL A5

Hazard statements (CLP)

H315, H319

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

No additional information available

Hazard pictograms

GHS07

Signal word

Warning

Hazard statements

H315 - Causes skin irritation. H319 - Causes serious eye irritation.

Precautionary statements

P264 - Wash hands thoroughly after handling. P280 - Wear eye protection, protective gloves. P302+P352 - IF ON SKIN: Wash with plenty of water. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337+P313 - If eye irritation persists: Get medical advice/attention. P501 - Dispose of contents and container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.

Supplemental label elements

EUH208 - Contains GLUTARAL. May produce an allergic reaction.

2.3 Other hazards

Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component glutaraldehyde (111-30-8) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component glutaraldehyde(111-30-8) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605

2.1 Classification of the substance or mixture

H315 Serious eye damage/eye irritation, Category 2 H319 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects No additional information available 2.2. Label elements Labelling according to Regulation (EC) No. 1272/2008 [CLP]